Introduction {#s1}
============

Brucellosis, also known as undulant or Malta fever, is one of the most common bacterial zoonoses endemic in many countries, particularly developing ones [@pone.0005368-Boschiroli1]. Brucellosis is caused by the genus *Brucella*, which consists of seven species according to antigenic variation and primary host. In general, humans can be infected by *B. melitensis*, *B. abortus*, and *B. suis*. The pathological manifestations of *Brucellosis* in humans include meningitis, endocarditis, spondylitis, and arthritis. *Brucella* infection occurs through inhalation or ingestion of the organisms. Following penetration of the epithelium, the bacteria are transported, either free or within phagocytes, to the regional lymph nodes and then to different tissues [@pone.0005368-Ko1]. *Brucella* species can survive within professional and non-professional phagocytes. Mutant strains that lose intracellular survival cannot carry out infection of their host; therefore, the virulence of *Brucella* depends upon its ability to survive and replicate within host cells.

For successful intracellular survival, an invading bacterial pathogen must overcome the bactericidal mechanisms employed by its host [@pone.0005368-Lin1]. Intracellular bacterial pathogens have developed various ways to circumvent host defense or bacterial degradation, such as controlling the maturation of their hosts\' membrane-bound compartments and transforming them into nutrient-rich environments where they can replicate [@pone.0005368-Celli1], [@pone.0005368-Pitt1], [@pone.0005368-PizarroCerda1], [@pone.0005368-PizarroCerda2]. Following internalization, *Brucella* redirects the vacuolar traffic in a way that avoids endocytosis and inhibits phagosome-lysosome fusion [@pone.0005368-Celli1]. *Brucella* transits through the cell via the autophagosome-like *Brucella*-containing vacuole (BCV). Subsequent interactions of this BCV with the ER membrane allow its maturation into an intracellular replication compartment where the bacteria can multiply. *Brucella* displays unique virulence characteristics, as many typical virulence determinants, including type I, II, and III secretion systems and pathogenicity islands, are absent from this bacteria. Therefore, the underlying virulence mechanisms employed by *Brucella* remain largely unknown. In a mutant screen for *B. suis* virulence factors, the *virB* operon (*virB*) consisting of 11 open-reading frames was found to be essential for *B. suis* persistence in mice [@pone.0005368-OCallaghan1]. *VirB* shares homology with other bacterial type IV secretion systems involved in intracellular trafficking and survival. *VirB* is also induced in macrophages, where it is required for localization of *Brucella* to mature BCV [@pone.0005368-Celli1].

Biochemical and pathological studies further define the roles of *virB* in *Brucella* survival. *Brucella* invasion induces acidification of the intracellular environment, which can enhance *virB* expression [@pone.0005368-Taminiau1]. Furthermore, *virB* mediates BCV maturation [@pone.0005368-Comerci1], and is essential for bacterial survival in both the early and late stages of infection. In early infection, BCV of *virB* mutant but not wild type *Brucella* fuse with host cell lysosomes, resulting in degradation of the mutant but not the wild type pathogen. In the late stages of infection, *virB* is indispensable for sustained interactions between *Brucella* and the ER, and hence BCV maturation [@pone.0005368-Celli1]. It is also important to note that *virB* is tightly regulated throughout this process of host invasion and bacterial replication. As is the case for other secretion system, *virB* is tightly regulated by other signals, and its main functions are carried out by the effectors molecules. These molecules regulate expression of other genes or interact with host cell. C Nijskens et al proved that the effectors secreted by a WT strain could rescue the trafficking deficiency of a ΔvirB mutant during co-infection in cells [@pone.0005368-Nijskens1]. Taken together, these results suggest that *virB* mediates *Brucella* survival by affect expression of other genes and modifying signaling pathways of host cells. The identification of these affected genes will provide more information about the function and virulence roles of *virB*.

Our goal of the present study was to identify the genes affected by *virB*, thereby explaining the molecular mechanisms underlying *Brucella* virulence and the role of *virB*. A comparative proteome approach was used to identify the differentially expressed proteins affected by *virB*. Several of differentially expressed proteins were selected for transcription during macrophage infection. The results indicated that *virB* affect the expression of a number of other proteins, which may be involved in *Brucella* intracellular survival.

Materials and Methods {#s2}
=====================

Construction and complementation of the virB mutant BMΔvirB {#s2a}
-----------------------------------------------------------

A *virB* inactivation mutant BMΔvirB (BM with promoter of the *virB* operon deleted) and complementary strains BM-IVGT (BMΔvirB containing complementary plasmid pBBR1-IVGT) were constructed from *B. melitensis* 55009, a strain derived from 16 M. The 1.7 kb *SacB* was released from pKOBEG-*SacB* by NdeI and cloned into the *Nde*I site of pUC19 to give pUC19-*SacB*. This allowed positive selection of double cross-over events using sucrose resistance as selection. A 504 bp region just upstream of *vir*B1 was deleted as follows: The N-terminal fragment was amplified with primers IVB-N-F and IVB-N-R, and the C-terminal fragment with IVB-C-F and IVB-C-R. The two PCR products were purified, equally mixed, and then amplified with IVB-N-F and IVB-C-R to generate IVB that was cloned into pUC19-*SacB* to generate pUC*SacB*-IVB. BM was electroporated with pUC*SacB*-IVB and amp^S^ sucrose^R^ colonies were isolated. The unmarked deletion mutant was further confirmed by PCR and DNA sequencing.

The complementary strain of BMΔvirB was constructed as follows: A 1087 bp fragment located downstream of the *vir*B operon was amplified with IVGT-F and IVGT-R and cloned into pUC19 to generate the targeted plasmid pUC19-IVT. This plasmid was transformed into competent BM, resulting in the targeted strain BM-IVT. Genomic DNA was extracted from BM-IVT and digested with *Eco*T22I, and then purified, self-ligated, and transformed into DH5α to rescue the plasmid pUC19-IVGT. The rescued *vir*B operon in pUC19-IVGT was confirmed by PCR with primers for *vir*B1, *vir*B2, *vir*B5, and *vir*B8. PCR products were sequenced to confirm the sequence. The two termini of the rescued fragment were confirmed by sequencing with sequencing primers of pUC19. The *vir*B operon was released from pUC19 by digestion with *Kpn*I and *Pst*I and then subcloned into pBBR1MCS-5 to generate pBBR1-IVGT. The plasmid pBBR1-IVGT was electroporated into the BM**Δ**virB mutant, resulting in the complementary strain BM-IVGT. The complementary strain was confirmed by semi-quantitative RT-PCR for *vir*B1 and *vir*B8.

Determination of in vitro induction conditions for virB {#s2b}
-------------------------------------------------------

*Brucella* was grown in TSB to the logarithm phase (*OD* ~600~ = 1.0) at 37°C and then subjected to different stress conditions modified from previous study [@pone.0005368-TeixeiraGomes1]. The bacteria were subjected to TSB4.0 (acid shock), TSB5.5 (acid shock), GEM7.0 (MgSO~4~.7H~2~O 0.2 g/L,Citric acid. H~2~O 2.0 g/L,K~2~HPO~4~ 10.0 g/L,NaNH~4~HPO~4~.4H~2~O 3.5 g/L,Glucose 20 g/L, pH 7.0 , limited nutrition) [@pone.0005368-Kulakov1] , GEM4.0 (limited nutrition and acid shock), TSB with 1.5 mM H~2~O~2~ (oxidative stress), TSB with 50 mM H~2~O~2~ (oxidative stress), 42°C (heat shock), TSB7.0 (control) for 30 min. Then, the transcription of *virB* under these stresses was compared by quantitative RT-PCR.

Preparation of the whole cell protein extract {#s2c}
---------------------------------------------

The BM and BMΔvirB strains were grown in TSB at 37°C to the middle logarithmic phase (*OD~600~* = 1.0), and then transferred to the stress condition where *virB* was greatly activated. Bacterial cells were harvested by centrifugation and cell pellets were re-suspended in 5 ml of lysis buffer (7 M urea, 2 M thiourea, 4% (w/v) CHAPS, and 50 mM DTT) containing complete protease inhibitors (Roche Applied Science, Indianapolis, IN). The cells were sonicated for 10 min on ice using a Sonifier 750 (Branson Ultrasonics Corp., Danbury, CT) with the following parameters: 2 s of sonication with a 2 s interval, 35% duty cycle. After addition of 2.5 mg of RNase (Promega, Madison, WI) and 100 units of DNase (Promega, Madison, WI), the cell lysate was incubated for 1 h at 15°C to solubilize proteins. The lysate was then centrifuged at 20,000 g for 20 min to pellet the insoluble components. The supernatant was collected, and protein concentration was measured using the PlusOne 2-D Quant kit (Amersham Pharmacia Biotech, Sweden). 800 µg aliquots of the purified proteins were stored at −70°C.

Two-dimensional Polyacrylamide Gel Electrophoresis {#s2d}
--------------------------------------------------

Two-dimensional polyacrylamide gel electrophoresis (2-DE) was performed as follows: 18 cm IPG strips (pH ranges, 4--7) (Amersham Pharmacia Biotech) were used for isoelectric focusing (IEF). 800 µg of total protein extract was loaded and IEF was conducted at 20°C for 50,000 Vhrs. The maximum voltage and current were set as 8,000 V and 50 µA/strip, respectively. After IEF, each strip was equilibrated in 10 ml equilibration buffer 1 (6 M urea, 0.5% DTT, 30% glycerol, 50 mM Tris-Cl pH 8.8) for 15 min, and then in 10 ml of equilibration buffer 2 (6 M urea, 4.5% iodoacetamide, 30% glycerol, 50 mM Tris-Cl pH 8.8) for another 15 min. The vertical slab SDS--PAGE (12.5%) was run with 30 mA/gel in a ProteanTM II XL system (Bio-Rad, Hercules, CA). Preparative gels used for identification of proteins by mass spectrometry were stained with Coomassie Brilliant Blue R-350 (Ameresco Co., Solon, OH, USA). Gels were scanned and images were analyzed with ImageMaster™ 2D Platinum software (Amersham Biosciences, Uppsala, Sweden). The relative volume of each spot was determined from the spot intensities in pixel units and normalized to the sum of the intensities of all the spots of the gel. Proteins with at least 2-fold volume variations were considered to be differentially expressed.

In-gel protein digestion {#s2e}
------------------------

The protein spots of interest were cut out of the gel and de-stained with 50 µl of 25 mM ammonium bicarbonate in 50% acetonitrile (ACN) for 30 min at room temperature for three times. The de-stained gel pieces were completely dried in a SpeedVac vacuum concentrator (Savant Instruments, Farmingdale, NY, USA). The gels were re-swollen with 3 µl of 25 mM ammonium bicarbonate containing 10 µg of trypsin at 4°C for 1 h. After 12 h of incubation at 37°C, the gels were dried under high vacuum centrifuge to evaporate the solvent. 8 µl of 5% trifluoroacetic acid (TFA) was added to the gel spots and incubated at 37°C for 1 h. The supernatant was transferred into a new microtube. 8 µl of 2.5% TFA in 50% ACN was added and incubated at 30°C for 1 h. The supernatant was transferred to a new microtube. At last 8 µl 100% ACN was used for extraction of hydrophobic peptides. All of the supernatants were combined and dried in the SpeedVac vacuum concentrator, and re-solubilized with 3 µl of 0.5% TFA in 30% ACN.

MALDI-TOF-MS {#s2f}
------------

All matrix-assisted laser desorption/ionization time-of-flight mass spectroscopy (MALDI-TOF-MS) measurements were performed on a Bruker Reflex III MALDI-TOF-MS (Bruker Daltonik, Bremen, Germany) operating in reflectron mode. A saturated solution of CHCA in 50% ACN and 0.1% TFA was used as the matrix solution. One microliter of the matrix solution and sample solution with a 1∶1 ratio were mixed and applied onto the Score384 target well. The MALDI-TOF-MS analysis was performed at 20 kV accelerating voltage and 23 kV reflecting voltage.

Peptide mass fingerprinting {#s2g}
---------------------------

Peptide mass fingerprinting (PMF) searches were performed by using the program MASCOT developed by Matrix Science (<http://www.matrixscience.com>). For protein identification, peptide masses searches against the NCBInr database with free access on the Internet were done. Monoisotopic peptide masses were used to search the databases, allowing a peptide mass accuracy of 100 ppm and one partial cleavage. The search parameters were: maximum of one missed cleavage by trypsin; fixed modification of oxidized methionine. Using these parameters and searching only the *B. melitensis* 16 M database, probability based MOWSE scores greater than 48 are significant (p\<0.05). For unambiguous identification of proteins more than five peptides must be matched and the sequence coverage must be greater than 15%.

RNA Sample Preparation and cDNA Synthesis {#s2h}
-----------------------------------------

For transcription analysis of *virB* under in vitro conditions, bacteria were cultured in TSB to logarithmic phases (*OD~600~* = 1.0) and then subjected under specific conditions. Total RNA were isolated with Trizol agent (Invitrogen, Carlsbad, CA) as recommended by the manufacturer. RNA samples were then treated with DNAse I (Promega, Madison, WI) to remove any contaminating genomic DNA. RNA quantity and quality was assessed using ND-1000 Spectrophotometer Nanodrop (Technologies, CA). Complementary DNA (cDNA) was generated from total RNA using a random hexamer primer following the protocol for Superscript II (Invitrogen, Carlsbad, CA).

Semi-quantitative RT-PCR {#s2i}
------------------------

For simi-quantitative RT-PCR analysis, 16S rRNA, whose transcription is relatively constant in bacterial, was chosen as internal control. Different cDNA samples were amplified with primers for 16S rRNA, and the cDNA samples were normalized by differential dilutions according to quantity of 16S rRNA products. Then, selected genes were amplified from normalized cDNA samples with specific primers (The primers used for RT-PCR assays were listed in [Table 1](#pone-0005368-t001){ref-type="table"}). The PCR products were analyzed on 1.2% agarose gel and visualized by ethidium bromide staining.

10.1371/journal.pone.0005368.t001

###### Primers used in this study.

![](pone.0005368.t001){#pone-0005368-t001-1}

  Primers                   Sequences (5′--3′)
  ------------- ------------------------------------------
  IVB-N-F            CTGCGAAGCTTGCAAATTCCCGTCCGGTTCG
  IVB-N-R        GAGGACAAGGAATGGCACCACGACGCAGGACGGAAAGGAC
  IVB-C-F        GTCCTTTCCGTCCTGCGTCGTGGTGCCATTCCTTGTCCTC
  IVB-C-R            CGACCGGAATTCGAAGCCGCCCGTAAAGTTGC
  IVGT-F          ACGTCGGATCCGAATTCACAGGCATTATCCGCTCGTC
  IVGT-R          AGTCGAAGCTTTCTAGAAGCATAGCCAGTAGGTCCAG
  PRO-F                    GAGCGGCTGGAACTGCAAAC
  PRO-R                   GACCAACCGCCCACCAACGAC
  virB1-RT-F               AAGCAATCACGACAGCACAG
  virB1-RT-R              CGGCGTAGTAACAGGAGAATG
  virB8-RT-F               GGGCTTTCGGCACCATTAC
  virB8-RT-R               AGCGTGTACCAGTCGTAGG
  16sRNA-RT-F              CACTGGACCATTACTGACGC
  16sRNA-RT-R               ACTAAGGGCGAGGGTTGC
  dnaK-RT-F                 TGAAATGGCAGCCGATAA
  dnaK-RT-R                 AAGCGAGGTCTTGAGGG
  gntR-RT-F                AAAATGACCGAAGCATCTGG
  gntR-RT-R                 TGCGGGAAATGGGACGAA
  htrA-RT-F               TTTGGCGACGATAATAAGGTG
  htrA-RT-R                 ATGGCGAGAAGATGGCG
  omp25-RT-F                CAGCACCGTTGGCAGCAT
  omp25-RT-R                GGCATAACCGGGTTCAGG
  vjbR-RT-F                 CGAGGTGGAGGACGAAGA
  vjbR-RT-R                 ATAATGCCGAGGGAAAGC

Real-Time Quantitative RT-PCR (qRT-PCR) {#s2j}
---------------------------------------

Samples were run in triplicate and amplified in a 20 µl reaction containing 10 µl of 2×SYBR Green I Master Mix (TAKARA, Japan), 100 nM of forward/reverse primer, and 1 µl of cDNA target. Moreover, no-template controls were used as recommended. The mix was incubated at 95°C for 15 s, and then cycled at 95°C for 5 s and at 60°C for 20 s 50 times using the Roche LightCycler2.0 system. Relative transcriptional level was determined by the methods of 2^−ΔΔCt^ as described previously [@pone.0005368-Livak1]. Relative fold change (Treatment/control) = 2^−ΔΔCt^, where ΔCt (Gene of interest) = Ct (Gene of interest)-Ct (Reference gene of the same sample) and ΔΔCt (Gene of interest) = ΔCt (Treatment)−ΔCt (Control). The 16S rRNA, the expression of which is relatively constant in bacteria, was used as a reference gene and bacterial grown in TSB7.0 was used as the control.

Macrophage infection assay, growth curve and transcription analysis {#s2k}
-------------------------------------------------------------------

Macrophage cell infection was assayed as described earlier [@pone.0005368-Billard1]. Murine macrophage-like J774A.1 cells were seeded in 24-well plates at 5×10^5^ cells/well. Cells were incubated in 5% CO~2~ at 37°C for 8 h and then infected with *Brucella* at an MOI of 200. To synchronize the infection, the infected plates were centrifuged at 200 g for 5 min at room temperature. Following 60 min incubation, the cells were washed three times with PBS to remove extracellular bacteria. To assess intracellular growth of the bacterial, the cell were incubated for 1 h in DMEM/F12 supplemented with 100 µg/ml of ampicilin plus 50 µg/ml of kanamycin to kill extracellular bacteria, then the concentration of antibiotics were reduced to 20 µg/ml (time zero). At different time points post infection, the supernatant was discarded and cells were lysed with 0.1% (v/v) Triton X-100. The CFU were obtained by plating serial dilutions on TSA plates. All the infections were performed in triplicate and repeated for 3 times. For transcription analysis during macrophage infection, at different time points post infection, the total RNA was isolated with Trizol agent. The reverse transcription and qRT-PCR analysis was carried out as described above. RNA of J774A.1 uninfected was isolated as a negative control. For growth curve analysis, bacteria were grown in TSB for 24 h, and then diluted with TSB to OD~600~ = 0.05 and cultured at 37°C with shaking. Aliquots of the cultures were taken at an interval of 2 h and cell density OD~600~ was recoded. Transcription of *vir*B and *vjb*R at different growth stages were analyzed by qRT-PCR.

Results {#s3}
=======

Construction and confirmation of the virB mutant and complementary strains {#s3a}
--------------------------------------------------------------------------

The 11 sequential ORFs encoding Type IV secretion machinery comprise *vir*B, making *vir*B inactivation possible by promoter deletion. To construct an unmarked deletion mutant of *vir*B, the counter-selection gene *Sac*B was firstly cloned into pUC19 to give pUC19-*SacB*. This plasmid was then used to construct the *vir*B mutant as described above. The unmarked deletion mutant BMΔvirB, which resulted from two rounds of croos-over, was obtained by its amp^S^ and sucrose^R^ phenotypes (data not shown).

To construct the complementary strain, *vir*B was cloned by plasmid rescue and sub-cloned into pBBR1MCS5, a plasmid that could replicate in *Brucella* [@pone.0005368-Elzer1], [@pone.0005368-Elzer2], to yield complementary plasmid pBBR-IVGT. PCR verification and DNA sequencing showed that the virB operon was correctly rescued and cloned in pBBR-IVGT. This plasmid was transformed into BMΔvirB, generating the complementary strain BM-IVGT. PCR verification demonstrated that the promoter region was deleted in BMΔvirB and recovered in BM-IVGT ([Figure 1A](#pone-0005368-g001){ref-type="fig"}). Semi-quantitative RT-PCR indicated that transcription of the *vir*B genes *vir*B1 and *vir*B8 was detected in BM and BM-IVGT, but not BMΔvirB, indicating that *vir*B was successfully inactivated in BMΔvirB and restored in BM-IVGT ([Figure 1B](#pone-0005368-g001){ref-type="fig"}). Interestingly, transcription of *vir*B genes in BM-IVGT was higher than that in BM ([Figure 1B](#pone-0005368-g001){ref-type="fig"}). pBBR1MCS5 is a wide host range plasmid that could replicate in *Brucella* in multi-copy[@pone.0005368-Elzer1], [@pone.0005368-Elzer2]. This might be the reason for the increased transcription of *vir*B genes in BM-IVGT compared to BM.

![Construction and confirmation of BMΔvirB and BM-IVGT strains.\
A) The promoter was amplified from BM and BM-IVGT, but not from BMΔvirB, showing that the promoter was deleted in BMΔvirB and complemented in BM-IVGT. B) RT-PCR amplification of *vir*B1 and *vir*B8 showed that the two genes could be amplified from BM and BM-IVGT, but not BMΔvirB, indicating that transcription of *vir*B genes was inactivated in BMΔvirB and restored in BM-IVGT.](pone.0005368.g001){#pone-0005368-g001}

Determination of in vitro induction conditions for virB {#s3b}
-------------------------------------------------------

Although *virB* is mainly activated during host infection, it is also activated under in vitro conditions [@pone.0005368-Taminiau1]. Due to the difficulty in isolation of enough bacteria proteins from infection mixtures and the contamination of host cell proteins, we chose to compare proteomes of BM and BMΔvirB cultured in vitro. To greatly differentiate protein expressions between BM and BMΔvirB, we sought to compare their proteomes under in vitro conditions where *virB* was highly activated. To identify such conditions, BM was subjected to several in vitro stress treatments as described previously, and the relative transcription of the *virB* was quantified. *virB* was greatly activated in acidified minimum medium (GEM 4.0) ([Figure 2A](#pone-0005368-g002){ref-type="fig"}). To ensure that nutrition limitation did not inhibit growth of *Brucella*, the incubation time in GEM 4.0 was determined. Transcription of *virB* peaked at 3 h ([Figure 2B](#pone-0005368-g002){ref-type="fig"}). Therefore, 3 h of incubation in GEM 4.0 was used in comparative proteomic analyses.

![Determination of in vitro induction conditions of *virB*.\
A: Transcription of *virB* under different in vitro condition. BM was firstly cultured in TSB to logarithmic phase and then subjected to different stresses. RNA was isolated and transcription of *virB* was quantified by qRT-PCR. *virB* was greatly activated under GEM4.0. B: Transcription of *virB* at different incubation time in GEM4.0. BM was subjected to different incubation time in GEM4.0 and then transcription of *virB* was quantified. The *virB* was greatly activated at 3 h.](pone.0005368.g002){#pone-0005368-g002}

Overview of the comparative proteome {#s3c}
------------------------------------

*Brucella* was firstly cultured in TSB to logarithmic phase, and then transferred to acidified minimum for 3 h of incubation. Whole cell proteins were extracted, followed by isoelectric focusing and SDS-PAGE. To obtain an overview of the protein distribution, we used pH 3--10 IPG strips (180 mm) first (data not shown). The result shows that most proteins\' pI is located between 4 and 7, so finally we chose the strips with a range of pH 4--7.

The typical proteome gel maps of BM and BMΔvirB are presented in [Figure 3](#pone-0005368-g003){ref-type="fig"}. A total of 951 and 964 protein spots were detected for strains BM and BMΔvirB, respectively. 910 protein spots of the two strains could be matched. The abundance of a protein is calculated as the Vol% which represents the ratio of it to all the detected protein spots. The relative expression change is the abundance ratio of a spot matched between the two strains. According to this criteria, those whose abundance changed 2 fold or greater were considered as greatly differentially expressed proteins. When compared with BM, 59 protein spots were down-regulated, and 36 were up-regulated in BMΔvirB. 19 protein spots were uniquely expressed in BM, and 27 in BMΔvirB (data not shown). These protein spots were cut out from the 2-DE gel and subjected to in gel digestion, followed by MALDI-TOF-MS identification. Peptide mass fingerprinting were searched with MASCOT for protein identification. Only those whose peptide covered more than 15% of the amino acid sequence were considered as positive identification. 76 protein spots representing products of 62 proteins were successfully identified. Of the 62 proteins, 44 proteins were downshifted or repressed in BMΔvirB, and 18 proteins were upshifted or induced ([Table 2](#pone-0005368-t002){ref-type="table"}). These differentially expressed proteins are mainly involved in amino acid transport and metabolism (10/62), lipid metabolism (4/62), energy production (6/62), cell membrane biogenesis (6/62), translation (5/62), post-translational modifications and protein turnover (5/62), as well as unknown proteins. Among the identified proteins, 34 were cytoplasmic proteins. Interestingly, several known virulence related proteins, including VjbR, HtrA, GntR, Omp25 and DnaK, were down-regulated when *virB* was inactivatived ([Figure 4A](#pone-0005368-g004){ref-type="fig"}).

![Proteomes of *B. melitensis* strains BM and BMΔvirB in the pH range of 4.0 to 7.0.\
BM (A) and BMΔvirB (B) were firstly cultured in TSB to logarithmic phase and then transferred into GEM4.0 for 3 h. Protein extracts (800 µg) of each strain were focused with IPG strips and run on 12% SDS-PAGE gels. The gels were stained with Coomassie Brilliant Blue R-350 and subjected to 2 DE analyses. The gels of BM and BMΔvirB were scanned and compared with ImageMaster™ 2D Platinum software. The labeled protein spots were the ones whose expressions were changed over 2 folds.](pone.0005368.g003){#pone-0005368-g003}

![Confirmation of comparative proteome by semi-quantitative RT-PCR.\
A: Spot distribution of the selected virulence related protein on gel of BM. Several protein spots with different MW and pI of *omp25* were identified. B: Relative transcription of virulence related genes in BM and BMΔvirB. BM and BMΔvirB were firstly cultured in TSB to logarithmic phase and then transferred into GEM4.0 for 3 h. RNA was isolated and relative transcription of virulence related genes was quantified by normalization with 16S rRNA. These genes were transcribed at a lower level in BMΔvirB than in BM.](pone.0005368.g004){#pone-0005368-g004}

10.1371/journal.pone.0005368.t002

###### List of differentially expressed proteins identified by MALDI-TOF-MS.

![](pone.0005368.t002){#pone-0005368-t002-2}

  Spot no                                                           NCBI GI        Locus      Gene                                   Protein description                                  Theoretical/Exptl   sequence coverage   COG[a](#nt101){ref-type="table-fn"}   Location[b](#nt102){ref-type="table-fn"}   Change fold[c](#nt103){ref-type="table-fn"}  
  -------------------------------------------------------------- -------------- ----------- -------- ----------------------------------------------------------------------------------- ------------------- ------------------- ------------------------------------- ------------------------------------------ --------------------------------------------- -------
  Energy production and conversion                                                                                                                                                                                                                                                                                                                              
  Q39                                                             gi\|17986535   BMEI0251     atpD                                 ATP synthase subunit B                                       55/34             5.48/4.95                      0.51                                      C                                            U                          Y
  Q1                                                              gi\|17989212   BMEII0867    adh                              alcohol dehydrogenase class III                                  40/41             6.03/6.63                      0.29                                      C                                            C                        −6.7
  Q47                                                             gi\|17988739   BMEII0394     \-                               glycerol trinitrate reductase                                   40/43             5.80/5.91                      0.35                                      C                                            C                        −4.8
  Q77                                                             gi\|17986535   BMEI0251     atpD                                 ATP synthase subunit B                                       55/31             5.48/4.88                      0.31                                      C                                            U                        −2.6
  Q3                                                              gi\|17989214   BMEII0869    putA                      succinate-semialdehyde dehydrogenase (NADP+)                            52/46             6.42/6.42                      0.41                                      C                                            C                        −2.0
  Q74                                                             gi\|17986422   BMEI0138     sucC                          succinyl-CoA synthetase subunit beta                                43/44             4.90/5.03                      0.54                                      C                                            C                        −2.0
  Q4                                                              gi\|17988102   BMEI1819     adh                              alcohol dehydrogenase class III                                  40/44             5.72/6.18                      0.44                                      C                                            C                         2.0
  Amino acid transport and metabolism                                                                                                                                                                                                                                                                                                                           
  Q27                                                             gi\|17989216   BMEII0871    aroE                                shikimate 5-dehydrogenase                                     30/31             5.99/6.64                      0.27                                      E                                            U                        −4.0
  Q10                                                             gi\|17987926   BMEI1643     argE                         N-carbamoyl-L-amino acid amidohydrolase                              45/51             5.17/5.30                      0.36                                      E                                            C                        −2.9
  Q51                                                             gi\|17989218   BMEII0873    livF       high-affinity branched-chain amino acid transport ATP-binding protein LivF             28/30             6.99/6.45                      0.70                                      E                                            C                        −2.7
  Q49                                                             gi\|17987935   BMEI1652     ureC                                  urease subunit alpha                                        61/33             5.43/5.97                      0.31                                      E                                            C                        −2.6
  Q7                                                              gi\|17988264   BMEI1981      \-                                     aminopeptidase T                                          46/45             5.65/5.90                      0.32                                      E                                            C                        −2.5
  Q50                                                             gi\|17987454   BMEI1171     argC                       N-acetyl-gamma-glutamyl-phosphate reductase                            34/37             5.89/6.27                      0.54                                      E                                            C                        −2.2
  Q35                                                             gi\|17987387   BMEI1104      \-                 arginine/ornithine-binding periplasmic protein precursor                      27/31             4.77/4.72                      0.61                                      ET                                           P                          T
  Q53                                                             gi\|17988946   BMEII0601     \-                       cystine-binding periplasmic protein precursor                           28/30             7.74/6.77                      0.54                                      ET                                           P                         9.3
  Q65                                                             gi\|17988895   BMEII0550    proX                     glycine betaine/l-proline-binding protein ProX                           32/32             5.57/5.34                      0.58                                      E                                            P                         2.2
  Q71                                                             gi\|17988978   BMEII0633    livK    leucine-, isoleucine-, valine-, threonine-, and alanine-binding protein precursor         39/40             5.52/5.62                      0.56                                      E                                            P                         2.2
  Q54                                                             gi\|17988946   BMEII0601     \-                       cystine-binding periplasmic protein precursor                           28/30             7.74/6.90                      0.54                                      ET                                           P                         2.1
  Nucleotide transport and metabolism                                                                                                                                                                                                                                                                                                                           
  Q30                                                             gi\|17987061   BMEI0778     adk                                     adenylate kinase                                          21/31             6.63/6.59                      0.57                                      F                                            C                        −2.1
  Carbohydrate transport and metabolism                                                                                                                                                                                                                                                                                                                         
  Q34                                                             gi\|17988062   BMEI1779     pfkB                                      Fructokinase                                            36/42             4.85/4.94                      0.60                                      G                                            C                          T
  Q43                                                             gi\|17986593   BMEI0310     gapA                        glyceraldehyde-3-phosphate dehydrogenase                              36/38             6.13/6.91                      0.71                                      G                                            C                         2.7
  Lipid transport and metabolism                                                                                                                                                                                                                                                                                                                                
  Q63                                                             gi\|17988859   BMEII0514    fabG                       3-ketoacyl-(acyl-carrier-protein) reductase                            27/31             5.44/5.52                      0.59                                     IQR                                           C                        −3.2
  Q73                                                             gi\|17988206   BMEI1923     caiA                              isovaleryl-CoA dehydrogenase                                    42/42             5.36/5.33                      0.53                                      I                                            U                        −2.2
  Q44                                                             gi\|17986323   BMEI0039     accA                acetyl-CoA carboxylase carboxyltransferase subunit alpha                      35/34             6.14/6.62                      0.70                                      I                                            C                        −2.1
  Q9                                                              gi\|17988206   BMEI1923     caiA                              isovaleryl CoA dehydrogenase                                    41/42             5.36/5.45                      0.44                                      I                                            U                        −2.0
  Q72                                                             gi\|17987756   BMEI1473      \-                       3-oxoacyl-(acyl carrier protein) synthase II                            44/48             5.36/5.50                      0.49                                      IQ                                           C                         2.3
  Translation                                                                                                                                                                                                                                                                                                                                                   
  Q8                                                              gi\|17987120   BMEI0837     gltX                                glutamyl-tRNA synthetase                                      55/49             5.85/5.66                      0.42                                      J                                            C                        −6.4
  Q24                                                             gi\|17988198   BMEI1915     rpsA                                30S ribosomal protein S1                                      64/33             5.19/5.67                      0.20                                      J                                            C                        −3.9
  Q46                                                             gi\|17983840   BMEI1806    trpRS                              tryptophanyl-tRNA synthetase                                    42/41             6.28/6.02                      0.27                                      J                                            C                        −2.6
  Q31                                                             gi\|17987025   BMEI0742     tuf                                   elongation factor Tu                                        43/43             5.29/5.57                      0.54                                      J                                            C                          T
  Q64                                                             gi\|17988070   BMEI1787     raiA             putative sigma54 modulation protein/SSU ribosomal protein S30P                   22/31             5.24/5.50                      0.67                                      J                                            U                         2.9
  Transcription                                                                                                                                                                                                                                                                                                                                                 
  Q26                                                             gi\|17989223   BMEII0878    gntR                         transcriptional regulator, GntR family                               26/32             6.15/6.61                      0.47                                      K                                            C                        −12.2
  Q29                                                             gi\|17989461   BMEII1116    vjbR                         transcriptional activator, LuxR family                               26/32             6.21/6.41                      0.80                                      K                                            U                        −2.0
  Cell wall/membrane biogenesis                                                                                                                                                                                                                                                                                                                                 
  Q13                                                             gi\|17989189   BMEII0844   omp31                   31 kDa outer-membrane immunogenic protein precursor                        23/45             5.21/5.08                      0.38                                      M                                           OM                          Y
  Q15                                                             gi\|17988112   BMEI1829    omp25c                  25 KDa outer-membrane immunogenic protein precursor                        25/45             4.79/4.57                      0.42                                      M                                           OM                          Y
  Q36                                                             gi\|17987532   BMEI1249    omp25                   25 KDa outer-membrane immunogenic protein precursor                        23/30             8.58/5.26                      0.31                                      M                                           OM                          Y
  Q37                                                             gi\|17988725   BMEII0380    acrA                        acriflavin resistance protein A precursor                             42/41             5.68/5.51                      0.30                                      M                                           CM                          Y
  Q38                                                             gi\|17987010   BMEI0727     ddl                               D-alanine--D-alanine ligase A                                   39/43             4.96/5.17                      0.41                                      M                                            C                          Y
  Q19                                                             gi\|17987532   BMEI1249    omp25                   25 KDa outer-membrane immunogenic protein precursor                        23/28             8.58/5.07                      0.47                                      M                                           OM                        −34.8
  Q17                                                             gi\|17988112   BMEI1829    omp25c                  25 KDa outer-membrane immunogenic protein precursor                        25/31             4.79/4.37                      0.42                                      M                                           OM                        −19.9
  Q23                                                             gi\|17987532   BMEI1249    omp25                   25 KDa outer-membrane immunogenic protein precursor                        23/26             8.58/5.67                      0.31                                      M                                           OM                        −19.2
  Q22                                                             gi\|17987532   BMEI1249    omp25                   25 KDa outer-membrane immunogenic protein precursor                        23/27             8.58/5.26                      0.44                                      M                                           OM                        −9.6
  Q12                                                             gi\|17987532   BMEI1249    omp25                   25 KDa outer-membrane immunogenic protein precursor                        23/41             8.58/5.26                      0.50                                      M                                           OM                        −9.1
  Q18                                                             gi\|17987532   BMEI1249    omp25                   25 KDa outer-membrane immunogenic protein precursor                        23/28             8.58/4.88                      0.21                                      M                                           OM                        −8.6
  Q16                                                             gi\|17987290   BMEI1007    omp25a                  25 KDa outer-membrane immunogenic protein precursor                        25/34             4.72/4.37                      0.42                                      M                                           OM                        −5.7
  Q58                                                             gi\|17987532   BMEI1249    omp25                   25 KDa outer-membrane immunogenic protein precursor                        23/25             8.58/5.68                      0.62                                      M                                           OM                        −3.9
  Q11                                                             gi\|17989189   BMEII0844   omp31                   31 kDa outer-membrane immunogenic protein precursor                        23/48             5.21/5.20                      0.38                                      M                                           OM                        −3.1
  Q20                                                             gi\|17987532   BMEI1249    omp25                   25 KDa outer-membrane immunogenic protein precursor                        23/28             8.58/4.69                      0.41                                      M                                           OM                        −2.8
  Q76                                                             gi\|17989189   BMEII0844   omp31                   31 kDa outer-membrane immunogenic protein precursor                        23/32             5.21/4.88                      0.49                                      M                                           OM                        −2.1
  Posttranslational modification, protein turnover, chaperones                                                                                                                                                                                                                                                                                                  
  Q14                                                             gi\|17988285   BMEI2002     dnaK                                molecular chaperone DnaK                                      69/40             4.86/4.82                      0.16                                      O                                            C                          Y
  Q75                                                             gi\|17988746   BMEII0401     \-                                        thioredoxin                                            35/37             4.94/5.03                      0.37                                      O                                            C                        −2.9
  Q6                                                              gi\|17987613   BMEI1330     htrA                                       protease DO                                            53/40             5.81/5.99                      0.17                                      O                                            U                        −2.4
  Q68                                                             gi\|17989393   BMEII1048   groEL                                    chaperonin GroEL                                          57/34             5.04/5.13                      0.27                                      O                                            C                        −2.3
  Q40                                                             gi\|17987352   BMEI1069      tf                                      trigger factor                                           54/58             4.94/5.07                      0.55                                      O                                            C                        −2.0
  Inorganic ion transport and metabolism                                                                                                                                                                                                                                                                                                                        
  Q60                                                             gi\|17988349   BMEII0005    modA                          molybdate-binding periplasmic protein                               25/29             5.31/5.44                      0.45                                      P                                            P                        −2.2
  Q32                                                             gi\|17988929   BMEII0584    afuA                     iron(iii)-binding periplasmic protein precursor                          36/38             5.20/5.17                      0.49                                      P                                            P                        −2.0
  Q28                                                             gi\|17988124   BMEI1841     sbp                             sulfate-binding protein precursor                                 36/41             5.47/6.07                      0.34                                      P                                            P                         4.0
  Q69                                                             gi\|17986956   BMEI0673     cysP                          thiosulfate-binding protein precursor                               37/37             5.31/5.23                      0.29                                      P                                            P                         2.3
  Q70                                                             gi\|17986956   BMEI0673     cysP                          thiosulfate-binding protein precursor                               37/37             5.31/5.34                      0.41                                      P                                            P                         2.3
  Q62                                                             gi\|17988952   BMEII0607    fatB                           ferric anguibactin-binding protein                                 31/33             5.36/5.64                      0.34                                      P                                            P                         2.2
  General function prediction only                                                                                                                                                                                                                                                                                                                              
  Q5                                                              gi\|17987208   BMEI0925     adh                                   alcohol dehydrogenase                                       35/37             5.56/5.99                      0.28                                      R                                            C                          Y
  Q21                                                             gi\|17986557   BMEI0273     glcG                                      GlcG protein                                            14/21             5.10/5.39                      0.61                                      R                                            U                        −5.0
  Q48                                                             gi\|17989217   BMEII0872    fabG                       3-ketoacyl-(acyl-carrier-protein) reductase                            28/36             5.57/6.07                      0.45                                      QR                                           C                        −3.0
  Q33                                                             gi\|17988824   BMEII0479     \-                         ABC transporter substrate-binding protein                             40/40             5.11/5.33                      0.39                                      R                                            U                         3.5
  Q52                                                             gi\|17987518   BMEI1235     fabG                                short-chain dehydrogenase                                     25/29             6.15/6.79                      0.61                                      QR                                           C                         3.4
  Intracellular trafficking and secretion                                                                                                                                                                                                                                                                                                                       
  Q25                                                             gi\|17986405   BMEI0121     secA                             protein translocase, chain secA                                 103/31             5.15/5.66                      0.20                                      U                                            C                        −5.3
  Function unknown                                                                                                                                                                                                                                                                                                                                              
  Q59                                                             gi\|17986596   BMEI0313     zapA                             Hypothetical Cytosolic Protein                                   13/15             4.78/4.81                      0.84                                      S                                            C                        −2.5
  Q42                                                             gi\|17987476   BMEI1193      \-                               cell wall degradation protein                                   45/43             7.03/6.90                      0.45                                      S                                            U                         2.2
  not in COGs                                                                                                                                                                                                                                                                                                                                                   
  Q41                                                             gi\|17986462   BMEI0178      \-                               hypothetical protein BMEI0178                                   18/52             4.79/5.03                      0.66                                      \-                                           U                        −5.9
  Q56                                                             gi\|17986457   BMEI0173      \-                                     YciI-like protein                                         40/14             5.52/5.74                      0.92                                      \-                                           U                        −5.0
  Q45                                                             gi\|17988858   BMEII0513    gpd                            glucose-6-phosphate 1-dehydrogenase                                55/31             5.74/6.54                      0.28                                      \-                                           U                        −3.6
  Q61                                                             gi\|17988500   BMEII0156    motD                                 chemotaxis motd protein                                      40/31             5.12/5.82                      0.17                                      \-                                           C                        −2.5
  Q2                                                              gi\|17987549   BMEI1266     pdxA                      4-hydroxythreonine-4-phosphate dehydrogenase                            43/39             9.13/6.63                      0.40                                      \-                                           C                        −2.3
  Q78                                                             gi\|17986825   BMEI0542      \-                               hypothetical protein BMEI0542                                   30/30             4.83/4.79                      0.64                                      \-                                           U                        −2.2
  Q57                                                             gi\|17986528   BMEI0244      \-                                  putative translaldolase                                      23/30             5.69/5.72                      0.60                                      \-                                           U                         2.8
  Q55                                                             gi\|17987937   BMEI1654      \-                                   urease gamma subunit                                        9/14              5.54/6.49                      0.89                                      \-                                           C                         2.1

Abbreviation of cellular role categories of theoretical (<http://www.ncbi.nlm.gov/COG/>).

Abbreviation of cellular location. Protein cellular location was annotated by PSORTb V. 2.0 (<http://www.psort.org/>). C: Cytoplasmic, P: Periplasmic, U: Unknown, OM: OuterMembrane, CM: CytoplasmicMembrane.

Proteins upshifted in the BMΔvirB mutant are marked with "+", and those downshifted with "−"; unique protein spots in BM are marked with "Y", and in BMΔvirB with "T".

virB affect expression of proteins of several function categories {#s3d}
-----------------------------------------------------------------

### Outer membrane proteins {#s3d1}

After inactivation of *virB*, the greatest protein expression change was observed in the outer membrane proteins. In the genome of *B. melitensis*, 4 omp25 genes are predicted: BMEI1249 (omp25), BMEI1007 (omp25a), BMEI1829 (omp25c) and BMEI1830 (omp25d). Of the 4 genes, products of 3 of them (BMEI1007, BMEI1249 and BMEI1829) were detected to be differentially expressed. Interestingly, Omp25 and Omp25c were assigned more than one protein spots on the 2-DE profiles. 8 protein spots of BMEI1249 and 2 of BMEI1829 were detected. All these protein spots were down-regulated in BMΔvirB. Omp25 belongs to the OmpA protein family, whose abundance accounts for 30--40% of the outer membrane. The different protein spots might come from post translation modification or breakdown of OmpA proteins, which has been observed in many other bacteria genus. Omp31 is one of the protective antigens of *Brucella*. It is also a hemin binding protein involved in iron uptake. Different products of Omp31 were also observed on 2-DE gel. 3 protein spots of omp31 were all down-regulated in BMΔvirB. Besides omp25 and omp31, some other outer membrane proteins, such as AcrA and Imp, were also down-regulated in *virB* mutant.

### Heat shock response proteins {#s3d2}

To survive in hostile environments, intracellular bacteria induce a number of stress response proteins to adapt to the hostile environments in host cell. In the present study, we found that some heat shock proteins and molecular chaperons were down-expressed in BMΔvirB. These proteins included serine protease HtrA (spot Q6), molecular chaperon DnaK (spot Q14), trigger factor Tf (spot Q40), and chaperonin GroEL (spot Q68). HtrA is generally thought to serve as a stress response protease in the periplasmic space, degrading damaged proteins resulted from a variety of environmental stresses, including elevated temperatures and reactive oxygen intermediates. HtrA is important for adapting to the intracellular environment of host macrophages [@pone.0005368-Elzer2]. Previous studies showed that DnaK was important for *Brucella* growth and survival under stress conditions and macrophage infection. The constitutive *dnaK* mutant failed to multiply in murine macrophage-like cells and was rapidly eliminated in a mouse infection model, implying stress-mediated and heat shock promoter-dependent induction of *dnaK* is a crucial event in the intracellular replication of *B. suis* [@pone.0005368-Kohler1]. Tf is an ATP-independent chaperone and displays chaperone and peptidyl- prolyl-cis-trans-isomerase activities in vitro. In the *E.coli* cytosol, Tf was found to be the first chaperone that binds to the nascent polypeptide chain [@pone.0005368-Valent1]. Moreover, recently Tf was revealed for the first time as a protective antigen against Brucellosis, implying its important roles [@pone.0005368-Yang1].

### Energy production and conversion {#s3d3}

A number of proteins associated with energy production and metabolism were also down-expressed in the BMΔvirB. Those proteins including ATP synthase subunit B AtpD (spot Q39 and Q77), alcohol dehydrogenase class III adh (spot Q1), succinate-semialdehyde dehydrogenase PutA (spot Q3), glycerol trinitrate reductase (spot Q47), and succinyl-CoA synthetase subunit beta SucC (spot Q74). AtpD was down-expressed in BMΔvirB, implying ATP synthesis may be reduced, which can influence the energy production. The downshift of acetyl-CoA carboxylase carboxyltransferase subunit alpha AccA (spot Q44) and 3-ketoacyl-(acyl-carrier-protein) reductase FabG (spot Q63) in BMΔvirB indicated down-regulation of fatty acid metabolism. Adipoid, especial phosphatide and cholesterol are the main components of cell membrane, which keep the integrity of the cell membrane. Down-regulation of those proteins may affect the integrity of the cell membrane and may alter resistance of the pathogen against hostile environments in the host. In addition, some proteins associated with amino acid transport and metabolisms were also down-expressed in the BMΔvirB. These include shikimate 5-dehydrogenase AroE (spot Q27), N-acetyl-gamma-glutamyl-phosphate reductase ArgC (spot Q50), and high-affinity branched-chain amino acid transport ATP-binding protein LivF (spot Q51). It is possible that the down-regulation of these proteins might result in decreased levels of ATP.

### Iron metabolism {#s3d4}

In pathogenic bacteria, iron acquisition is critical for the survival in infection. After inactivation of *virB*, expression of some proteins associated with iron metabolism was changed. Ferric anguibactin-binding protein FatB (sport 62) was up- regulated, while iron (iii)-binding periplasmic protein precursor AfuA (sport 32) was down-regulated. AfuA was responsible for junction and transportation of iron. Down-regulated this protein may influence the ability of iron transportation and acquisition of BMΔvirB.

### Transcription and Translation {#s3d5}

GntR (spot Q26) and VjbR (spot Q29) belong to transcriptional regulatory proteins, which involved in virulence gene control in *B. melitensis*. They were down-regulated in BMΔvirB. GntR is a major global regulation protein in *B. melitensis* 16 M. Previous study showed that GntR control *virB* at the transcriptional level. GntR mutant showed decreased survival in cellular models and mice modals. The requirement of a functional *gntR* gene for survival or proliferation in BALB/c mice spleen suggests that the absence of an appropriate control of the Ashwell pathway unsettled the sugar metabolism of the bacteria in mice [@pone.0005368-Haine1]. VjbR is a member of the family of LuxR, which belong to the quorum sensing system. Previous studies proved that VjbR can regulate the expression of *virB*, which was consistent with our results [@pone.0005368-Delrue1]. Down-regulated of this protein may influence virulence of the mutant. Additionally, some proteins associated to protein synthesis were also down-regulated in BMΔvirB. These proteins included glutamyl-tRNA synthetase GltX (spot Q8), tryptophanyl tRNA synthetase TrpRS (spot Q46) and 30S ribosomal protein S1 RpsA(spot Q24). Down regulation of these proteins might result in decreased synthesis of some related proteins.

VirB affects transcription of dnaK, vjbR, omp25, htrA and gntR during macrophage cell infection {#s3e}
-----------------------------------------------------------------------------------------------

Among the identified proteins, several known virulence related proteins, including VjbR, HtrA, GntR, Omp25 and DnaK, were down-regulated when *virB* was inactivatived ([Figure 4A](#pone-0005368-g004){ref-type="fig"}). Simi-quantitative RT-PCR of these genes showed that transcription of them was decreased in the *virB* mutant ([Figure 4B](#pone-0005368-g004){ref-type="fig"}), being consistent with results from comparative proteomes, indicating that these genes were affected by the *virB*.

Because *virB* is primarily activated during infection, we attempted to test whether these virulent genes were affected by the *virB* during macrophage cell infection. Firstly, quantitative real time PCR method was developed for these genes. Total RNA was isolated from infection mixtures of macrophages and bacteria followed by DNase I treatment and reverse transcription. Coding region of *omp25* could be amplified from cDNA and DNA, but not RNA, indicating that the RNA was not contaminated by DNA (data not shown). By using cDNA from infection mixtures or uninfected macrophage as template, *virB*, *dnaK*, *htrA*, *omp25* and *gntR* was amplified with SYBR Green I method. All of them showed a unique Tm for infection mixture but not for uninfected macrophage, indicating that the amplification is specific (data not shown). Amplification efficiencies of these genes are all close to 2. Taken together, the real time PCR could be used for relative transcription quantification.

Then we analyzed the transcription of *virB* genes during host cell infection. To obviate the possibility of transcription preference, *virB1* and *virB8*, two genes located at different locus of the *virB* operon, were selected. The two genes showed identical transcription profiles, confirming that the *virB* is an operon, and any one of its genes can represent its transcription ([Figure 5A](#pone-0005368-g005){ref-type="fig"}). As shown in [figure 5B](#pone-0005368-g005){ref-type="fig"}, immediately after enter macrophage, the *virB* was activated, and the transcription peaked at 12 h post the infection and then decreased.

![Transcriptional profile of *virB* during host cell infection.\
Macrophage like cell J774A.1 were infected with BM, BMΔvirB and BM-IVGT. At different time (0, 12, 24 and 48 h) post the infection, RNA was isolated from the infection mixtures and reverse transcribed into cDNA. Transcription of *virB* genes were then quantified by qRT-PCR. A: Relative transcription of *virB1* and *virB8*. The *virB1* and *virB8* was identically transcribed. B: Relative transcription of *virB8* in BM, BMΔvirB and BM-IVGT. Transcription of *virB8* peaked at 12 h and then decreased in BM and BM-IVGT. No transcription of *virB8* was detected in BMΔvirB and uninfected macrophage cells.](pone.0005368.g005){#pone-0005368-g005}

Then, transcription of *dnaK*, *vjbR*, *omp25* (BMEI1249), *htrA* and *gntR* in BM, BMΔvirB and BM-IVGT were quantified and compared. For BM, *dnaK*, *vjbR*, *omp25*, *htrA* and *gntR* were transcribed at a very low level in vitro (TSB 7.0), but were highly activated immediately in macrophage, indicating these genes play important role in *Brucella* intracellular survival. Transcription of *htrA* peaked at 0 h, *vjbR* and *dnaK* at 12 h, and *gntR* at 24 h, implying that they function at different stage of infection ([Figure 6](#pone-0005368-g006){ref-type="fig"}). The transcription of these genes were greatly decreased in BMΔvirB, but were recovered to some extent in BM-IVGT, indicating that transcriptions of these genes are regulated by the *virB* operon in a positive manner.

![Transcription of *vjbR*, *dnaK*, *htrA*, *omp25*, and *gntR* during host cell infection (⧫--- BM; ▪ --- BMΔvirB; ▴ --- BM-IVGT; •---BLANK).\
Macrophage cells were infected with BM, BMΔvirB and BM-IVGT. At different time (0, 12, 24 and 48 h) post the infection, RNA was isolated from the infection mixtures and reverse transcribed into cDNA. Transcription of selected genes was then quantified by qRT-PCR.](pone.0005368.g006){#pone-0005368-g006}

virB positively regulates vjbR in a cell density--dependent manner {#s3f}
------------------------------------------------------------------

Transcription analyses of in vitro stress, macrophage infection, and mouse models indicated that *vir*B positively regulates *vjb*R, a quorum sensing (QS) regulator that functions in a cell-dependent manner. To test whether the *vir*B regulated *vjb*R in a cell density--dependent manner, the transcription of *vir*B and *vjb*R at different growth phases were compared. *vir*B and *vjb*R had similar transcription profiles ([Figure 7A](#pone-0005368-g007){ref-type="fig"}). Their transcription peaked during the early logarithmic phase and was down-regulated with cell density increase, indicating their growth phase--dependent transcription.

![*vir*B positively regulates *vjb*R.\
A) Transcription of *vjb*R and *vir*B8 during the early logarithmic (EL), mid-logarithmic (ML), late logarithmic (LL), and stationary phases (SP) demonstrate that *vjb*R and *vir*B8 are greatly transcribed in EL and ML. B) Transcription of *vjb*R in BM, BMΔvirB, and BM-IVGT at EL, ML, LL, and SP show that v*jb*R is down-regulated at EL in BMΔvirB. C) BMΔvirB demonstrated higher growth rate than BM and BM-IVGT. D) *vir*B and *vjb*R positively regulate each other and form a positive regulation circuit.](pone.0005368.g007){#pone-0005368-g007}

We then compared the transcription of *vjb*R in BM, BMΔvirB, and BM-IVGT at different growth phases. Compared to BM, transcription of *vjb*R was decreased in BMΔvirB and recovered in BM-IVGT. Transcription of *vjb*R in BMΔvirB peaked at the mid-logarithmic phase, in contrast to BM and BM-IVGT ([Figure 7B](#pone-0005368-g007){ref-type="fig"}). *vjb*R seemed to inhibit growth of *Brucella* to some extent [@pone.0005368-Delrue1]. To test whether BMΔvirB has growth defects, the growth rates of the 3 bacteria were compared. BMΔvirB had a higher growth rate than BM ([Figure 7C](#pone-0005368-g007){ref-type="fig"}). In the BM-IVGT mutant, where *vir*B is highly transcribed, the growth rate was inhibited, implying that *vir*B has inhibitory effects on growth of *Brucella* ([Figure 7C](#pone-0005368-g007){ref-type="fig"}).

Based on these observations, it can be concluded that *vjb*R is positively regulated by *vir*B. On the other hand, the *vjb*R mutant has down-regulated expression of *vir*B, indicating that *vir*B is also positive regulated by *vjb*R [@pone.0005368-Delrue1]. Therefore, *vir*B and *vjb*R positively regulate one another, forming a positive regulation circuit ([Figure 7D](#pone-0005368-g007){ref-type="fig"}).

Discussion {#s4}
==========

Pathogen-host interactions during bacterial infection expose bacteria to multiple physiological and biological stresses, and intracellular pathogens are known to adapt to changes in their environment, avoiding degradation by host cell defense systems by coordinated regulation of gene expression. The *virB* operon is essential for intracellular survival and chronic infection of several *Brucella* species [@pone.0005368-OCallaghan1], and previous studies implied that this operon regulates virulence genes that are also important for *Brucella* survival [@pone.0005368-Celli1], [@pone.0005368-Comerci1]. So far, many studies proved that T4SS is essential for bacterial survival, but there have no reports on the proteins that affected by the *virB* operon. In the present study, comparative proteome approach was used to define the potential target proteins affected by *virB*.

A number of heat shock proteins and molecular chaperons were down-shifted in BMΔvirB. These proteins play an essential role as part of protein repair systems in protecting the bacteria under the environment encountered in the phagosome, and degrading damaged proteins resulting from exposure to a variety of environmental stresses, including elevated temperatures and exposure to reactive oxygen intermediates. At the same time, these proteins are involved in folding and proper localization of virulence factors. DnaK is a heat shock protein previously shown to be important for bacterial growth and survival under conditions of high temperature, low pH, oxidative stress, and macrophage infection [@pone.0005368-Kohler1], [@pone.0005368-Kohler2]. It is speculated that *dnaK* induction, possibly through low pH or starvation, is required for correct synthesis of certain virulence proteins that mediate *Brucella* survival during stress [@pone.0005368-Kohler2]. DnaK activation was partially dependent on *virB*, as its induction was inhibited in BMΔvirB. Bacterial stress response proteins of the high temperature requirement A (HtrA) family are serine proteases which appear to play an important role in scavenging oxidatively damaged proteins from the cell before they reach toxic levels [@pone.0005368-Laskowska1], [@pone.0005368-Lipinska1], [@pone.0005368-Strauch1]. The necessity for HtrA in virulence is believed to be related to its ability to protect cells from the products of the oxidative burst of host macrophages. *Brucella htrA* mutants have been described as being temperature sensitive, sensitive to oxidative killing in vitro, sensitive to killing by macrophages, and attenuated in both mice and ruminants [@pone.0005368-Elzer2], [@pone.0005368-Elzer3], [@pone.0005368-Phillips1]. These characteristics are consistent with the proposed function of the HtrA protease and similar to those described for *htrA* mutants of *Escherichia coli*, *Yersinia enterocolitica*, and *Legionella pneumophila* [@pone.0005368-Lipinska1], [@pone.0005368-Li1], [@pone.0005368-Yamamoto1]. Down-regulation of these heat shock proteins and molecular chaperones in BMΔvirB implied that *virB* might affect *Brucella* adaptation to in vitro and in vivo environments.

Intracellular proteolytic degradation is important in bacteria for the elimination of damaged proteins, modulation of protein levels, and maintenance of amino acid pools. Proteolytic enzymes represent one of the best investigated classes of proteins. For many years it was accepted that proteolytic enzymes functioned primarily in the acquisition of nutrients for growth and proliferation through the degradation of host tissues. However, recent observations indicated that pathogen-derived proteolytic enzymes also play important roles in the regulation of critical host processes, which is critical for survival of the invading microbes in a hostile host environment [@pone.0005368-Maeda1]. Proteins involved in proteolytic degradation, including heat shock protein, molecular chaperon and proteolytic enzymes are crucial for the intracellular survival of *Brucella*. Two proteolytic enzymes were down-expressed in BMΔvirB. This indicated that the *virB* operon is also needed to eliminate damaged proteins for *Brucella*.

Bacteria have the capability to express an appropriate subset of genes conferring a growth or survival advantage in a given situation. The expression of bacterial genes is regulated at the initiation of transcription by regulators which, in response to specific environmental and/or cellular signals, bind at the promoter of target genes to activate or repress them. Several important virulence related proteins involved in intracellular survival, including VjbR, DnaK, HtrA, Omp25, and GntR, were down-regulated in BMΔvirB. Quantitative RT-PCR showed that transcription of these virulence related genes was also affected by *virB* during macrophage cell infection. This was consistent with an observed decreased survival of the *virB* mutant in macrophage (data not shown), indicating that *virB* may mediate *Brucella* intracellular survival by affecting the expression of virulence related genes.

Intracellular pathogens are known to adapt to changes in their environments in order to survive under the stresses encountered in host cells [@pone.0005368-TeixeiraGomes1]. Acidic intraphagosomal pH developed from proton pump activation [@pone.0005368-Geisow1], and bacteria are generally sensitive to low pH. However, *Brucella* can survive at pH 4. Indeed, studies suggest that early (but not late) acidification of BCVs may lead to gene expression required for *Brucella* to adapt to and survive in its host [@pone.0005368-Porte1]. *VirB* is activated in the early stages of host cell infection, and blocking early acidification inhibits both expression of *virB* and *Brucella* survival [@pone.0005368-Taminiau1]. Our results indicated that *virB* and the virulence related genes affected by the *virB* operon were also activated during early infection. Thus, *Brucella* may adapt to its intracellular environment and avoid degradation by the coordinated regulation of gene expression in the early phase of infection.

Type IV secretion machinery is a membrane associated structure. Disruption of this structure seemed to result in great modifications in membrane and other components. Omp25 is a trans-membrane protein that is present on the outer membrane of *Brucella* and is probably covalently bound to the underlying peptidoglycan layer of the cell [@pone.0005368-Cloeckaert1]. Regarding virulence, mutant of *B. melitensis*, *B. abortus*, and *B. ovis* strains with the *omp25* gene inactivated have been found to be attenuated in mice, goats, and cattle [@pone.0005368-Edmonds1], [@pone.0005368-Edmonds2], [@pone.0005368-Edmonds3]. Additionally, Omp25 is also an important immune response regulator, and may mediate inhibition the host cell production of TNF-α [@pone.0005368-JubierMaurin1]. Indeed, down-regulation of Omp25 and subsequent production of TNF-α may be one reason for the high clearance of the *virB* mutant from its host. Iron acquisition is critical for the survival of pathogenic bacteria during infection. Successful pathogenic bacteria have evolved a variety of strategies in order to acquire iron from the iron or haem resources of mammalian hosts. In our study we found that iron metabolism was changed in BMΔvirB. Previous study proved that haem may be a relevant iron source for *Brucella* during intracellular replication. Outer membrane protein Omp31 present in most *Brucella* species is a haemin-binding protein. Down-expressed of Omp31 may reduce the iron acquisition in BMΔvirB. We presumed that the altered iron metabolism and down-expressed of Omp31 may influence the iron acquisition, and therefore affected the bacteria survival during intracellular infection.

Two QS genes have been predicted in *Brucella*, one of which (*vjbR*) is involved in *Brucella* virulence [@pone.0005368-Taminiau1], [@pone.0005368-Uzureau1]. The transcription analysis during macrophage infection indicates that *virB* positively regulates the expression of *vjbR*. Previous studies demonstrate that *virB* is also activated by *vjbR* [@pone.0005368-Delrue1]. It is possible that *virB* and *vjbR* may regulate each other, forming a regulation circuit. As *virB* encodes type IV secrection machinery, it may be that the effector proteins of *virB* are responsible for the directly regulation of *vjb*R. Therefore, identification of these effector proteins may provide insight into this regulation circuit.

The key function of T4SS of *Brucella* is to direct intracellular trafficking of BCV to reach replicative niche in the ER. And during this process, the effector proteins may play essential roles. A recent study showed that two proteins, VceA and VceC, were translocated by T4SS into macrophage[@pone.0005368-deJong1]. It is possible that the two effectors, and other unidentified effector proteins are involved in the *vir*B mediated *Brucella* intracellular survival. In the present study, by comparing the proteome of wild type strain and that of a *vir*B mutant under identical in vitro stress condition, a number of proteins of several categories were found to be differentially expressed. Because the in vitro condition is a stress condition that used to simulate intracellular environment, the differentially expressed proteins identified are mainly the ones involved in stress resistance mechanisms. Most of these proteins are possibly involved in *Brucella* adaptation to intracellular environments. The differential expression of stress response proteins seemed not to be contrast to the essential role of virB in BCV intracellular trafficking. During the intracellular process, it is very possible that the *vir*B also affects expression of other proteins. These proteins identified are mainly those affected indirectly by virB. Take into account previous study and results from our present study, it is possible that, beside secret effector proteins into host cells for intracellular survival, as a membrane structure, T4SS also affect expression of genes involved in adaptation to intracellular environments.

Conclusions {#s4a}
-----------

The analysis of a *virB* mutant using comparative proteomics and qRT-PCR defined the target proteins affected by the *virB* operon. The inactivation of the *virB* operon affected a series of known and unknown proteins and many of these differentially expressed proteins are involved in the adaptation of *Brucella* to intracellular environments. Therefore, in addition to the most important roles in intracellular trafficking of BCV, the *virB* operon may contribute the adaptation of *Brucella* to hostile environments and survival in the host cell by affecting the expression of proteins associated with the intracellular survival.
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